Current:Home > reviewsMac Jones benched after critical late interception in Patriots' loss to Colts -CapitalTrack
Mac Jones benched after critical late interception in Patriots' loss to Colts
View
Date:2025-04-14 01:41:17
The New England Patriots had one last gasp within minutes to score a go-ahead touchdown Sunday against the Indianapolis Colts.
Quarterback Mac Jones was not the one behind center in an attempt to lead the offense down the field in Germany.
New England benched Jones for the final drive following an interception he threw on the previous drive. From the Colts' 15-yard line and with the Patriots trailing 10-6, Jones took a snap on second-and-2 and targeted tight end Mike Gesicki – except the former first-round pick severely underthrew Gesicki, and Colts defensive back Julian Blackmon came up with the easy interception.
Said Jones after the game: "It was a terrible throw. Practiced it, hit it in practice. Just not a good throw. I knew where to go – I just didn't do it right."
Backup Bailey Zappe replaced Jones and the Patriots picked up two first downs. Disaster struck again for New England. Following a fake kneel attempt, Zappe threw over the middle of the field into a heavily covered area for an interception that effectively ended the game.
NFL STATS CENTRAL: The latest NFL scores, schedules, odds, stats and more.
After the game, Patriots coach Bill Belichick revealed little on the reasoning behind the change.
"I just thought it was time for a change," said Belichick, who also refused to commit to a starting quarterback moving forward.
Belichick also would not reveal whether Jones' health was a factor in the decision. Jones, who went into the X-ray room after the conclusion of the game, said after the game he was "bruised but good."
Jones was 15-for-20 for 170 yards prior to taking a seat.
The Patriots have now lost six of their last seven games and are on track to secure a top-five pick in the 2024 NFL draft.
veryGood! (168)
Related
- Gen. Mark Milley's security detail and security clearance revoked, Pentagon says
- Colleen Ballinger's Remaining Miranda Sings Tour Dates Canceled Amid Controversy
- Rooftop Solar Is Becoming More Accessible to People with Lower Incomes, But Not Fast Enough
- EPA Paused Waste Shipments From Ohio Train Derailment After Texas Uproar
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- These farmworkers thought a new overtime law would help them. Now, they want it gone
- Behavioral Scientists’ Appeal To Climate Researchers: Study The Bias
- After a Decade, Federal Officials Tighten Guidelines on Air Pollution
- Pressure on a veteran and senator shows what’s next for those who oppose Trump
- NOAA Climate Scientists Cruise Washington and Baltimore for Hotspots—of Greenhouse Gases and Air Pollutants
Ranking
- Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
- The EPA Is Helping School Districts Purchase Clean-Energy School Buses, But Some Districts Have Been Blocked From Participating
- Pregnant Kourtney Kardashian Bares Her Baby Bump in Leopard Print Bikini During Beach Getaway
- 'Hospital-at-home' trend means family members must be caregivers — ready or not
- North Carolina trustees approve Bill Belichick’s deal ahead of introductory news conference
- House Republicans' CHOICE Act would roll back some Obamacare protections
- 2022 Will Be Remembered as the Year the U.S. Became the World’s Largest Exporter of Liquified Natural Gas
- Jennifer Aniston’s Go-To Vital Proteins Collagen Powder and Coffee Creamer Are 30% Off for Prime Day 2023
Recommendation
Charges tied to China weigh on GM in Q4, but profit and revenue top expectations
Study: Higher Concentrations Of Arsenic, Uranium In Drinking Water In Black, Latino, Indigenous Communities
How to Watch the 2023 Emmy Nominations
How Should We Think About the End of the World as We Know it?
Gen. Mark Milley's security detail and security clearance revoked, Pentagon says
Summer School 2: Competition and the cheaper sneaker
Colleen Ballinger's Remaining Miranda Sings Tour Dates Canceled Amid Controversy
An experimental Alzheimer's drug outperforms one just approved by the FDA